Market research

Elderly Enteral Feeding Devices Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

16report chapters

360iResearch introduction

Public research overview

Elderly Enteral Feeding Devices: Executive Overview

Elderly enteral feeding devices support nutrition delivery when swallowing is unsafe or oral intake is insufficient. The clinical pathway spans nasogastric, gastrostomy, and jejunal access, together with pumps, administration sets, syringes, connectors, and securement products. Demand is shaped by population ageing, stroke, dementia, neurodegenerative disease, cancer, frailty, and post-acute recovery, while device selection depends on aspiration risk, treatment duration, care setting, functional status, and caregiver capability.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Device Type

    • Feeding Tubes
    • Feeding Pumps
    • Administration Sets
    • Accessories
    View chapter
  2. Chapter 8 Age Group

    • Young-Old (65–74 years)
    • Middle-Old (75–84 years)
    • Old-Old (85+ years)
    View chapter
  3. Chapter 9 Product Material

    • Silicone
    • Polyurethane
    • PVC
    View chapter

Care Delivery Is Shifting Toward Safer, More Integrated Feeding

The landscape is moving from isolated devices toward coordinated feeding systems that support safety, continuity, and home-based care. Enteral nutrition increasingly requires standardized connector compatibility, clearer labeling, pump accuracy, tube-placement verification, clog prevention, skin protection, and infection-control routines. Hospitals, rehabilitation facilities, long-term-care providers, and families also need training and escalation pathways because complications can arise from dislodgement, leakage, blockage, intolerance, dehydration, or medication administration errors. Reusable workflows are being complemented by single-use components where infection prevention and convenience are priorities.

Artificial Intelligence Strengthens Risk Detection and Care Coordination

Artificial intelligence can contribute through decision support, documentation assistance, remote monitoring, and pattern recognition rather than replacing clinical judgment. Algorithms may help identify patients at risk of malnutrition, aspiration, tube complications, or inadequate delivery by combining clinical records, intake data, vital signs, and caregiver observations. Image-assisted verification and anomaly detection could support placement and pump surveillance, but performance depends on representative data, validated clinical endpoints, cybersecurity, interoperability, and transparent human oversight. Any deployment should be governed through clinical validation, privacy controls, bias testing, and clear accountability for alerts and decisions.

Regional Insights: Ageing, Infrastructure, and Home-Care Capacity Shape Adoption

North America combines advanced hospital infrastructure with substantial home enteral nutrition activity, making training, reimbursement alignment, interoperability, and caregiver support important priorities. Europe emphasizes coordinated healthcare delivery, patient safety, and regulatory compliance, while differences among national systems affect access and discharge pathways. Asia-Pacific contains rapidly ageing populations alongside wide variation in hospital capacity, rural access, and home-care availability. Latin America is influenced by urban-rural disparities, public-sector procurement, affordability, and nutrition-service capacity. The Middle East is investing in specialized healthcare while navigating workforce and supply-chain variation. Africa faces uneven access to nutrition support, limited specialist coverage in many settings, and a strong need for durable, affordable devices and practical training.

Group Insights: Economic and Institutional Networks Influence Care Models

ASEAN markets reflect diverse levels of ageing, manufacturing capability, hospital access, and reimbursement, so scalable training and adaptable device configurations are important. BRICS members span large and unequal healthcare systems, creating demand for local capacity building, reliable distribution, and solutions suited to both tertiary hospitals and lower-resource settings. The European Union benefits from common regulatory structures while retaining national differences in reimbursement and service organization. G7 systems generally have mature clinical standards and home-care pathways but face workforce pressure and complex chronic-care needs. GCC countries are expanding specialized services and may prioritize centralized procurement, digital coordination, and hospital-to-home continuity. NATO members share preparedness and interoperability considerations, but enteral feeding access remains primarily a civilian health-system and ageing-care issue.

Country Insights: Diverse Demographics Require Locally Adapted Strategies

Australia and Canada must balance geographically dispersed populations with strong clinical standards and home-care delivery. Brazil, Mexico, India, and Russia face substantial regional variation in specialist access, affordability, and distribution. China is managing rapid ageing alongside expansion of hospital and community-care capacity. France, Germany, Italy, Spain, and the United Kingdom have established clinical systems but differ in reimbursement, procurement, discharge coordination, and long-term-care organization. Japan and South Korea are confronting pronounced ageing and increasing demand for coordinated nutrition, rehabilitation, and home-care services. Across the United States, hospital, post-acute, and home settings require alignment among clinicians, suppliers, payers, and caregivers, particularly for training and continuity after discharge.

Recommendations for Leaders: Build Safety, Continuity, and Usability Into Every Pathway

Industry leaders should design around complete care pathways rather than individual components. Priorities include interoperable connectors and accessories, intuitive pump interfaces, securement and skin-care options, clog-resistant workflows, clear medication-administration guidance, and packaging that supports correct use. Evidence programs should measure clinically meaningful outcomes such as unplanned tube replacement, aspiration events, infection indicators, delivery adherence, caregiver burden, and avoidable readmissions. Organizations should pair products with competency-based training, multilingual instructions, remote support, and escalation protocols. Regional strategies should account for infrastructure, procurement rules, reimbursement, workforce skills, and local service partners, while digital and AI features should launch only with validated performance, privacy safeguards, and human review.

Research Methodology: Evidence-Led Review of Clinical, Demographic, and System Factors

This executive summary uses a structured qualitative assessment of publicly documented clinical practice, demographic ageing patterns, healthcare-delivery characteristics, regulatory considerations, and technology developments relevant to elderly enteral feeding. The analysis compares device functions and care settings across the specified regions, groups, and countries, emphasizing recurring needs such as safety, usability, continuity, infection prevention, and caregiver support. Findings are framed as directional insights rather than market estimates. Interpretation should be updated as clinical guidelines, reimbursement policies, device standards, demographic data, and post-market safety evidence evolve.

Conclusion: Better Enteral Care Depends on Connected, Patient-Centered Systems

Elderly enteral feeding devices are increasingly part of a broader nutrition-support pathway extending from acute care to rehabilitation, long-term care, and the home. The strongest opportunities for better outcomes lie in combining dependable hardware with validated clinical protocols, caregiver education, equitable access, and coordinated follow-up. Regional and country differences make flexible implementation essential, while artificial intelligence should remain a carefully governed support capability. Leaders that prioritize safety, usability, interoperability, and measurable patient outcomes will be better positioned to strengthen nutrition delivery for older adults.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Elderly Enteral Feeding Devices Market, by Device Type
    1. 7.1Introduction
    2. 7.2Feeding Tubes
    3. 7.3Feeding Pumps
    4. 7.4Administration Sets
    5. 7.5Accessories
  8. 8.Elderly Enteral Feeding Devices Market, by Age Group
    1. 8.1Introduction
    2. 8.2Young-Old (65–74 years)
    3. 8.3Middle-Old (75–84 years)
    4. 8.4Old-Old (85+ years)
  9. 9.Elderly Enteral Feeding Devices Market, by Product Material
    1. 9.1Introduction
    2. 9.2Silicone
    3. 9.3Polyurethane
    4. 9.4PVC
  10. 10.Elderly Enteral Feeding Devices Market, by Distribution Channel
    1. 10.1Introduction
    2. 10.2Online
    3. 10.3Offline
  11. 11.Elderly Enteral Feeding Devices Market, by Region
    1. 11.1Introduction
    2. 11.2Asia-Pacific
    3. 11.3North America
    4. 11.4Latin America
    5. 11.5Europe
    6. 11.6Middle East
    7. 11.7Africa
  12. 12.Elderly Enteral Feeding Devices Market, by Group
    1. 12.1Introduction
    2. 12.2ASEAN
    3. 12.3GCC
    4. 12.4European Union
    5. 12.5BRICS
    6. 12.6G7
    7. 12.7NATO
  13. 13.Elderly Enteral Feeding Devices Market, by Country
    1. 13.1Introduction
    2. 13.2United States
    3. 13.3Canada
    4. 13.4Mexico
    5. 13.5Brazil
    6. 13.6United Kingdom
    7. 13.7Germany
    8. 13.8France
    9. 13.9Russia
    10. 13.10Italy
    11. 13.11Spain
    12. 13.12China
    13. 13.13India
    14. 13.14Japan
    15. 13.15Australia
    16. 13.16South Korea
  14. 14.Competitive Landscape
    1. 14.1Market Share Analysis, 2025
    2. 14.2Market Concentration Analysis, 2025
      1. 14.2.1Concentration Ratio (CR)
      2. 14.2.2Herfindahl Hirschman Index (HHI)
    3. 14.3Recent Developments & Impact Analysis, 2025
    4. 14.4Product Portfolio Analysis, 2025
    5. 14.5Benchmarking Analysis, 2025
  15. 15.Company Profiles
    1. 15.1Abbott Laboratories
    2. 15.2Alcor Scientific Inc
    3. 15.3Amsino International Inc
    4. 15.4Applied Medical Technology Inc
    5. 15.5Avanos Medical Inc
    6. 15.6B. Braun Melsungen AG
    7. 15.7Baxter International Inc
    8. 15.8Becton, Dickinson and Company
    9. 15.9Bionix Development Corporation
    10. 15.10Boston Scientific Corporation
    11. 15.11Cardinal Health Inc
    12. 15.12Conmed Corporation
    13. 15.13Cook Medical LLC
    14. 15.14Danone SA
    15. 15.15Danumed Medizintechnik GmbH
    16. 15.16Degania Silicone Ltd
    17. 15.17ENvizion Medical Ltd
    18. 15.18Fidmi Medical
    19. 15.19Flexicare Medical Limited
    20. 15.20GBUK Enteral Ltd
    21. 15.21Gravitas Medical Inc
    22. 15.22ICU Medical Inc
    23. 15.23Medcaptain Medical Technology Co Ltd
    24. 15.24Medline Industries LP
    25. 15.25Moog Inc
    26. 15.26Nutricia NV
    27. 15.27Rockfield Medical Devices Ltd
    28. 15.28Romsons Group of Industries
    29. 15.29Vesco Medical LLC
    30. 15.30Vygon SA
  16. 16.Key Experts

Loading the sample request form…